Healthcare -
Biotechnology - NASDAQ - US
$ 1.605
-6.14 %
$ 14.8 M
Market Cap
-0.25
P/E
Price Target
Average
286.29%
Revenue Forecast
Estimate
21.34%
EBIT
Estimate
61.70%
Net Income
Estimate
28.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
SAB Biotherapeutics, Inc.
Wall Street analysts predict an average 1-year price target for SABS of $6.2 , with forecasts ranging from
a
low of
$3 to a high of $8 .
SABS Lowest Price Target
Wall Street Target
3 USD
86.92%
SABS Average Price Target
Wall Street Target
6.2 USD
286.29%
SABS Highest Price Target
Wall Street Target
8 USD
398.44%
REVENUE FORECAST
Revenue Forecast Chart SABS
EBIT FORECAST
EBIT Forecast Chart SABS
NET INCOME FORECAST
Net Income Chart SABS